Skip to main content

Advertisement

SpringerLink
Log in

Apoptosis of human non-small-cell lung cancer A549 cells triggered by evodiamine through MTDH-dependent signaling pathway

  • Research Article
  • Published:
Tumor Biology

Abstract

Metadherin (MTDH), a novel oncoprotein, has been implicated in the carcinogenesis in various aspects of tumor malignancy. Overexpression of the MTDH promotes the survival and proliferation of lung cancer cells. Agent that can suppress MTDH activation would have potential to be developed for cancer therapeutics. In this study, we investigated the antitumor effect of evodiamine in human non-small-cell lung carcinoma (NSCLC) A549 cell line and the inhibitory effect of evodiamine on MTDH pathway. 3-(4,5-Dimethyl- thiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and annexin V/propidium iodide (PI) staining assays demonstrated that evodiamine or MTDH short hairpin RNA (shRNA) significantly inhibited proliferation of A549 cells via induction of apoptosis. Besides, evodiamine or MTDH shRNA-induced activation of the caspase-3 in A549 cells under same conditions. In addition, Western blotting analysis showed that treatment of A549 cells with evodiamine or MTDH shRNA resulted in an increase of proapoptotic protein Bax expression but decreased the expression levels of antiapoptotic protein Bcl-2 and MTDH, which altogether account for apoptotic cell death. Taken together, our results suggest that the evodiamine suppress the proliferation of lung cancer cells, at least, in part, via inhibition of MTDH expression and activation of apoptosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Yamanaka R. Medical management of brain metastases from lung cancer (review). Oncol Rep. 2009;22:1269–76.

    Article  CAS  PubMed  Google Scholar 

  2. Jemal A, Siegel R, Ward E. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43–66.

    Article  PubMed  Google Scholar 

  3. Alberg AJ, Samet JM. Epidemiology of lung cancer. Chest. 2003;123(1 Suppl):21S–49S.

    Article  PubMed  Google Scholar 

  4. Zochbauer-Muller S, Gazdar AF, Minna JD. Molecular pathogenesis of lung cancer. Annu Rev Physiol. 2002;64:681–708.

    Article  CAS  PubMed  Google Scholar 

  5. Erridge SC, Møller H, Price A, Brewster D. International comparisons of survival from lung cancer: pitfalls and warnings. Nat Clin Pract Oncol. 2007;4:570–7.

    Article  PubMed  Google Scholar 

  6. Park KI, Park HS, Kang SR, Nagappan A, Lee DH, Kim JA, et al. Korean Scutellaria baicalensis water extract inhibits cell cycle G1/S transition by suppressing cyclin D1 expression and matrix-metalloproteinase-2 activity in human lung cancer cells. J Ethnopharmacol. 2011;133:634–41.

    Article  PubMed  Google Scholar 

  7. Murer B. Targeted therapy in non-small cell lung cancer: a commentary. Arch Pathol Lab Med. 2008;132:1573–5.

    PubMed  Google Scholar 

  8. Kan SF, Yu CH, Pu HF, Hsu JM, Chen MJ, Wang PS. Anti-proliferative effects of evodiamine on human prostate cancer cell lines DU145 and PC3. J Cell Biochem. 2007;101:44–56.

    Article  CAS  PubMed  Google Scholar 

  9. Jiang J, Hu C. Evodiamine: a novel anti-cancer alkaloid from Evodia rutaecarpa. Molecules. 2009;14:1852–9.

    Article  CAS  PubMed  Google Scholar 

  10. Yu H, Jin H, Gong W, Wang Z, Liang H. Pharmacological actions of multi-target-directed evodiamine. Molecules. 2013;18:1826–43.

    Article  CAS  PubMed  Google Scholar 

  11. Shin YW, Bae EA, Cai XF, Lee JJ, Kim DH. In vitro and in vivo antiallergic effect of the fructus of Evodia rutaecarpa and its constituents. Biol Pharm Bull. 2007;30:197–9.

    Article  CAS  PubMed  Google Scholar 

  12. Chiou WF, Sung YJ, Liao JF, Shum AY, Chen CF. Inhibitory effect of dehydroevodiamine and evodiamine on nitric oxide production in cultured murine macrophages. J Nat Prod. 1997;60:708–11.

    Article  CAS  PubMed  Google Scholar 

  13. Kobayashi Y, Nakano Y, Kizaki M, Hoshikuma K, Yokoo Y, Kamiya T. Capsaicin-like anti-obese activities of evodiamine from fruits of Evodia rutaecarpa, a vanilloid receptor agonist. Planta Med. 2001;67:628–33.

    Article  CAS  PubMed  Google Scholar 

  14. Kobayashi Y. The nociceptive and anti-nociceptive effects of evodiamine from fruits of Evodia rutaecarpa in mice. Planta Med. 2003;69:425–8.

    Article  CAS  PubMed  Google Scholar 

  15. Rang WQ, Du YH, Hu CP, Ye F, Xu KP, Peng J, et al. Protective effects of evodiamine on myocardial ischemia-reperfusion injury in rats. Planta Med. 2004;70:1140–3.

    Article  CAS  PubMed  Google Scholar 

  16. Lin H, Tsai SC, Chen JJ, Chiao YC, Wang SW, Wang GJ, et al. Effects of evodiamine on the secretion of testosterone in rat testicular interstitial cells. Metabolism. 1999;48:1532–5.

    Article  CAS  PubMed  Google Scholar 

  17. Fei XF, Wang BX, Li TJ, Tashiro S, Minami M, Xing DJ, et al. Evodiamine, a constituent of Evodiae Fructus, induces anti-proliferating effects in tumor cells. Cancer Sci. 2003;94:92–8.

    Article  CAS  PubMed  Google Scholar 

  18. Yang ZG, Chen AQ, Liu B. Antiproliferation and apoptosis induced by evodiamine in human colorectal carcinoma cells (COLO-205). Chem Biodivers. 2009;6:924–33.

    Article  CAS  PubMed  Google Scholar 

  19. Huang H, Zhang Y, Liu X, Li Z, Xu W, He S, et al. Acid sphingomyelinase contributes to evodiamine-induced apoptosis in human gastric cancer SGC-7901 cells. DNA Cell Biol. 2011;30:407–12.

    Article  CAS  PubMed  Google Scholar 

  20. Yang L, Liu X, Wu D, Zhang M, Ran G, Bi Y, et al. Growth inhibition and induction of apoptosis in SGC‑7901 human gastric cancer cells by evodiamine. Mol Med Rep. 2014;9:1147–52.

    Article  CAS  PubMed  Google Scholar 

  21. Yang J, Wu LJ, Tashino S, Onodera S, Ikejima T. Protein tyrosine kinase pathway-derived ROS/NO productions contribute to G2/M cell cycle arrest in evodiamine-treated human cervix carcinoma HeLa cells. Free Radic Res. 2010;44:792–802.

    Article  CAS  PubMed  Google Scholar 

  22. Zhu LH, Liu XD, Tan YH, Li JF, Du BY, Wu YY. Proliferation-inhibited and apoptosis-inducted effects of evodiamine on human hepatoma cell line HepG2. Chin Pharmacol Bull. 2009;25:79–82.

    Google Scholar 

  23. Kan SF, Huang WJ, Lin LC, Wang PS. Inhibitory effects of evodiamine on the growth of human prostate cancer cell line LNCaP. Int J Cancer. 2004;110:641–51.

    Article  CAS  PubMed  Google Scholar 

  24. Wang C, Li S, Wang MW. Evodiamine-induced human melanoma A375-S2 cell death was mediated by PI3K/Akt/caspase and Fas-L/NF-kappaB signaling pathways and augmented by ubiquitin-proteasome inhibition. Toxicol In Vitro. 2010;24:898–904.

    Article  CAS  PubMed  Google Scholar 

  25. Ogasawara M, Matsunaga T, Takahashi S, Saiki I, Suzuki H. Anti-invasive and metastatic activities of evodiamine. Biol Pharm Bull. 2002;25:1491–3.

    Article  CAS  PubMed  Google Scholar 

  26. Liao CH, Pan SL, Guh JH, Chang YL, Pai HC, Lin CH, et al. Antitumor mechanism of evodiamine, a constituent from Chinese herb Evodiae fructus, in human multiple-drug resistant breast cancer NCI/ADR-RES cells in vitro and in vivo. Carcinogenesis. 2005;26:968–75.

    Article  CAS  PubMed  Google Scholar 

  27. Yoo BK, Gredler R, Vozhilla N, Su ZZ, Chen D, Forcier T, et al. Identification of genes conferring resistance to 5-fluorouracil. Proc Natl Acad Sci U S A. 2009;106:12938–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Kock N, Kasmieh R, Weissleder R, Shah K. Tumor therapy mediated by lentiviral expression of shBcl-2 and S-TRAIL. Neoplasia. 2007;9:435–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Jiang S, Zu Y, Fu Y, Zhang Y, Efferth T. Activation of the mitochondria-driven pathway of apoptosis in human PC-3 prostate cancer cells by a novel hydrophilic paclitaxel derivative, 7-xylosyl-10-deacetylpaclitaxel. Int J Oncol. 2008;33:103–11.

    CAS  PubMed  Google Scholar 

  30. Kawiak A, Zawacka-Pankau J, Lojkowska E. Plumbagin induces apoptosis in Her2-overexpressing breast cancer cells through the mitochondrial-mediated pathway. J Nat Prod. 2012;75:747–51.

    Article  CAS  PubMed  Google Scholar 

  31. Alosi JA, McDonald DE, Schneider JS, Privette AR, McFadden DW. Pterostilbene inhibits breast cancer in vitro through mitochondrial depolarization and induction of caspase-dependent apoptosis. J Surg Res. 2010;161:195–201.

    Article  CAS  PubMed  Google Scholar 

  32. Shang LH, Li CM, Yang ZY, Che DH, Cao JY, Yu Y. Luffa echinata Roxb. induces human colon cancer cell (HT-29) death by triggering the mitochondrial apoptosis pathway. Molecules. 2012;17:5780–94.

    Article  CAS  PubMed  Google Scholar 

  33. Rasul A, Yu B, Zhong L, Khan M, Yang H, Ma T. Cytotoxic effect of evodiamine in SGC-7901 human gastric adenocarcinoma cells via simultaneous induction of apoptosis and autophagy. Oncol Rep. 2012;27:1481–7.

    CAS  PubMed  Google Scholar 

  34. Saraste A, Pulkki K. Morphologic and biochemical hallmarks of apoptosis. Cardiovasc Res. 2000;45:528–37.

    Article  CAS  PubMed  Google Scholar 

  35. Danial NN, Korsmeyer SJ. Cell death: Critical control points. Cell. 2004;116:205–19.

    Article  CAS  PubMed  Google Scholar 

  36. Ghavami S, Hashemi M, Ande SR, Yeganeh B, Xiao W, Eshraghi M, et al. Apoptosis and cancer: mutations within caspase genes. J Med Genet. 2009;46:497–510.

    Article  CAS  PubMed  Google Scholar 

  37. Lavrik IN, Golks A, Krammer PH. Caspases: pharmacological manipulation of cell death. J Clin Invest. 2005;115:2665–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature. 1994;371:346–7.

    Article  CAS  PubMed  Google Scholar 

  39. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, et al. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell. 1995;81:801–9.

    Article  CAS  PubMed  Google Scholar 

  40. Orrenius S. Mitochondrial regulation of apoptotic cell death. Toxicol Lett. 2004;149:19–23.

    Article  CAS  PubMed  Google Scholar 

  41. van Laethem A, van Kelst S, Lippens S, Declercq W, Vandenabeele P, Janssens S, et al. Activation of p38MAPK is required for Bax translocation tomitochondria, cytochrome c release and apoptosis induced by UVB irradiation in human keratinocytes. FASEB J. 2004;18:1946–8.

    PubMed  Google Scholar 

  42. Vander Heiden MG, Thompson CB. Bcl-2 protiens: regulators of apoptosis or of mitochondrial homeostasis. Nat Cell Biol. 1999;1:209–16.

    Article  Google Scholar 

  43. Gross A, McDonald JM, Stanely J, Korsmeyer J. Bcl-2 family members and the mitochondria in apoptosis. Genes Dev. 1999;13:1899–911.

    Article  CAS  PubMed  Google Scholar 

  44. Luo Y, Zhou H, Mizutani M, Mizutani N, Reisfeld RA, Xiang R. Transcription factor Fos-related antigen 1 is an effective target for a breast cancer vaccine. Proc Natl Acad Sci U S A. 2003;100:8850–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Yu C, Chen K, Zheng H, Guo X, Jia W, Li M, et al. Overexpression of astrocyte elevated gene-1 (AEG-1) is associated with esophageal squamous cell carcinoma (ESCC) progression and pathogenesis. Carcinogenesis. 2009;30:894–901.

    Article  CAS  PubMed  Google Scholar 

  46. Kikuno N, Shiina H, Urakami S, Kawamoto K, Hirata H, Tanaka Y, et al. Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity. Oncogene. 2007;26:7647–55.

    Article  CAS  PubMed  Google Scholar 

  47. Emdad L, Sarkar D, Su ZZ, Randolph A, Boukerche H, Valerie K, et al. Activation of the nuclear factor kappaB pathway by astrocyte elevated gene-1: implications for tumor progression and metastasis. Cancer Res. 2006;66:1509–16.

    Article  CAS  PubMed  Google Scholar 

  48. Lee SG, Su ZZ, Emdad L, Sarkar D, Fisher PB. Astrocyte elevated gene-1 (AEG-1) is a target gene of oncogenic Ha-rasrequiring phosphatidylinositol 3-kinase and c-Myc. Proc Natl Acad Sci U S A. 2006;103:17390–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

This work was supported by the National Science Foundation of China (No. 81201779) and Wu Jieping Medical Fund (No. 320.6750.1264).

Conflicts of interest

None

Author information

Author notes

    Authors and Affiliations

    1. Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China

      Yanmei Zou & Hua Xiong

    2. Department of Gynaecology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, 441021, China

      Xiaomin Qin

    3. Department of Biochemistry and Molecular Biology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China

      Feng Zhu

    4. Department of Cardiothoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China

      Tao Chen

    5. Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China

      Hongge Wu

    Authors
    1. Yanmei Zou
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Xiaomin Qin
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Hua Xiong
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. Feng Zhu
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. Tao Chen
      View author publications

      You can also search for this author in PubMed Google Scholar

    6. Hongge Wu
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding author

    Correspondence to Hongge Wu.

    Additional information

    Yanmei Zou and Xiaomin Qin contributed equally to this work.

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Zou, Y., Qin, X., Xiong, H. et al. Apoptosis of human non-small-cell lung cancer A549 cells triggered by evodiamine through MTDH-dependent signaling pathway. Tumor Biol. 36, 5187–5193 (2015). https://doi.org/10.1007/s13277-015-3174-z

    Download citation

    • Received:

    • Accepted:

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s13277-015-3174-z

    Keywords

    Search

    Navigation